| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |